TL;DR
Saw palmetto is a botanical 5-alpha-reductase inhibitor with small, consistent signals in the hair literature — the 2002 Prager trial, the 2012 Rossi comparative study, and the 2020 Skin Appendage Disorders systematic review all point in the same direction, but none of them demonstrate an effect on the scale of finasteride. It's a reasonable ingredient in a scalp serum. It is not a drug and should not be compared to one on performance.
What is DHT, and why do people care about it?
Dihydrotestosterone, or DHT, is an androgen. It's produced when the enzyme 5-alpha-reductase converts testosterone — an androgen your body produces in both men and women, in different amounts — into DHT. DHT is metabolically more potent than testosterone and binds to androgen receptors with higher affinity.
On the scalp, DHT is the molecule most closely associated with androgenetic alopecia — the pattern hair thinning that shows up as a receding hairline and crown thinning in men, and as diffuse thinning with a widening part in women. The American Academy of Dermatology's patient-facing resources describe the pattern in detail: on genetically susceptible follicles, DHT drives a process called miniaturization, where the follicle produces progressively finer, shorter strands over time until it eventually stops producing visible hair altogether.
This is the reason the DHT conversation matters at all. If you know your pattern is androgenetic, anything that credibly reduces scalp DHT is of interest.
What is saw palmetto?
Saw palmetto — Serenoa repens — is a small palm native to the southeastern United States. The berries have been used in traditional herbalism for centuries, primarily for urinary-tract complaints in older men. The active extract is standardized to around 85–95% fatty acids and sterols, and it's one of the more extensively studied botanicals in the broad category of "natural 5-alpha-reductase inhibitors."
The NIH Office of Dietary Supplements maintains a public fact sheet on saw palmetto (ods.od.nih.gov/factsheets) that summarizes the human evidence. The bulk of the clinical research concerns benign prostatic hyperplasia — prostate enlargement in older men — where saw palmetto has been investigated as an alternative to pharmaceutical 5-alpha-reductase inhibitors. That prostate literature is where its mechanism-of-action profile was established, and it's that same mechanism that made dermatology researchers curious about it as a topical hair ingredient.
How saw palmetto actually works (the mechanism)
The mechanism is straightforward enough to explain without oversimplifying: saw palmetto extract inhibits 5-alpha-reductase, the enzyme that converts testosterone to DHT.
Two subtleties matter.
First, 5-alpha-reductase exists in two main isoforms — type I and type II — distributed differently across tissues. Type II predominates in the prostate and the hair follicle's outer root sheath. Finasteride, the FDA-approved oral drug for male-pattern hair loss, is a selective type-II inhibitor. Dutasteride, also FDA-approved (though not for hair in the US), inhibits both. Saw palmetto extract inhibits both isoforms, but with considerably lower potency than either pharmaceutical agent. It's the right class, a much weaker member of it.
Second, inhibition at the follicle is a different question from inhibition systemically. Finasteride, taken orally, produces a measurable drop in serum DHT. Saw palmetto, whether taken orally or applied topically, produces smaller and more variable effects. Applied topically, the question of how much of the extract actually reaches the follicle's outer root sheath at meaningful concentration is still an open formulation question, not a settled one.
Bope and Kellerman's summary of 5-alpha-reductase inhibitors in Conn's Current Therapy is a useful clinical reference for the drug class as a whole — including why the enzyme has been a sustained pharmaceutical target and what its limitations are as a lever for hair outcomes.
What do the trials actually show?
Three trials are worth naming specifically.
Prager et al., 2002 — saw palmetto plus beta-sitosterol (oral)
Prager, Bickett, French and Marcovici published a small randomized, double-blind, placebo-controlled pilot study in the Journal of Alternative and Complementary Medicine in 2002. Twenty-six men with mild-to-moderate androgenetic alopecia received either an oral saw-palmetto-plus-beta-sitosterol formulation or placebo for roughly five months. Investigator assessment showed improvement in 60% of treated subjects versus 11% of placebo. The trial was small, it was investigator-funded, and the outcome measure was subjective, but it's the first commonly cited hair-specific trial for the ingredient, and the signal was non-trivial.
Rossi et al., 2012 — saw palmetto vs. finasteride (oral)
Rossi and colleagues, writing in the International Journal of Immunopathology and Pharmacology in 2012, ran a two-year, open-label comparative study of oral saw palmetto (320 mg/day) versus oral finasteride (1 mg/day) in men with androgenetic alopecia. 38% of the saw palmetto group showed improvement at two years. 68% of the finasteride group did. The saw palmetto group's improvements clustered on the vertex; finasteride showed improvement more broadly, including the frontal area. Limitations: the trial was open-label (no blinding), and compliance and drop-out were uneven. But it's the single most-cited head-to-head comparison, and it's the trial that sets the honest expectation: saw palmetto is in the right direction, at roughly half the effect size of finasteride.
Wessagowit et al., 2016 — topical Serenoa repens
Wessagowit and colleagues, publishing in the Australasian Journal of Dermatology in 2016, reported on a topical Serenoa repens lotion used twice daily for 24 weeks in men and women with androgenetic alopecia. The treated group showed increases in hair count and hair density versus baseline. The trial was small and lacked a placebo arm of comparable size, so the effect size should be read carefully. But it's the best-known topical-application study and the one that grounds the case for putting saw palmetto in a scalp serum at all.
The 2020 Skin Appendage Disorders systematic review
The systematic review by Evron, Juhasz, Babadjouni and Mesinkovska, published in Skin Appendage Disorders in 2020, pooled human trials of natural supplements and botanicals for hair loss. Saw palmetto is one of the few ingredients the authors called out as having consistent — if small-scale and often methodologically limited — evidence in the hair context. The review is the right starting reference for anyone trying to understand the honest state of the evidence across the botanical category, rather than for any single ingredient.
The thing these four references share is the same tone: consistent, small, directional signals — not drug-class magnitudes. Honest reading.
Saw palmetto vs. finasteride — the honest comparison
This section is the one that earns its place.
Finasteride is an FDA-approved oral drug. It has been shown in multi-year randomized placebo-controlled clinical trials — the Kaufman et al. trials are the most widely cited in the hair context — to reduce scalp DHT by roughly 60% and to slow and in some cases reverse hair loss in men with androgenetic alopecia. Those are drug claims, and they're factually correct because finasteride is a drug; they're not Unfurl's claims, and they're not claims a cosmetic product could legally make.
Saw palmetto, in the same condition, shows a smaller and more variable effect. If finasteride's effect size is around 1.0 in a rough approximation, saw palmetto's — across the oral literature — sits somewhere around 0.3 to 0.5. The 2012 Rossi comparative is the best direct-comparison anchor for that estimate.
Three honest conclusions follow:
- Saw palmetto is not a replacement for finasteride for someone who has tried finasteride, tolerated it, and wants to stop. The effect size is materially different.
- Saw palmetto may be a reasonable starting point for someone who hasn't tried a pharmaceutical route, wants to start with a gentler approach, and is willing to accept a smaller expected effect in exchange for a much lower side-effect profile.
- Saw palmetto is also reasonable for someone running a drug-class routine who wants a complementary topical — not because it boosts finasteride meaningfully, but because the scalp environment (antioxidant support, ingredient layering, clean routine) is something a cosmetic serum can genuinely address.
The midlife hair shift guide covers the particular case for women, where finasteride is generally off-label and the pharmacologic landscape (spironolactone, topical minoxidil, occasionally dutasteride) looks different.
Who might actually benefit?
A few honest segments:
- Men in the early stages of androgenetic alopecia who aren't ready to start finasteride. The 2002 Prager and 2012 Rossi trials are the populations most directly represented.
- Men on finasteride who want a complementary topical serum with a mechanistically aligned botanical. The case here isn't that saw palmetto adds to finasteride in some cumulative way; it's that a well-formulated serum addresses the scalp environment finasteride doesn't touch.
- Women with diffuse thinning who can't or don't want to take spironolactone, and whose dermatologist has ruled out treatable underlying causes. The evidence in women specifically is thinner than the evidence in men; the 2016 Wessagowit trial included both.
- Anyone whose scalp itches, flakes, or feels reactive and whose serum choice should center on scalp environment rather than DHT per se. Saw palmetto has a mild astringent profile that pairs with sebum-management considerations.
Saw palmetto is not a good fit for anyone with a known allergy to palm-family plants, anyone pregnant or nursing (oral or topical — run it past your OB), or anyone on blood thinners (the oral form has anticoagulant interaction potential; the NIH ODS fact sheet documents the relevant cautions).
What's a reasonable dose — orally and topically?
The oral dose most commonly studied in hair trials is around 320 mg/day of a standardized extract (85–95% fatty acids and sterols). The 2002 Prager trial used that range; Rossi's 2012 comparative used the same. The NIH ODS fact sheet notes the general oral-supplement range used in the broader literature falls between 160 and 320 mg twice daily.
Topical concentrations in serums are lower and more variable across the category. Wessagowit's 2016 lotion and subsequent commercial formulations typically sit in the low single-digit percentage range as part of a multi-ingredient serum. The honest read is that topical saw palmetto is a supporting active in a well-formulated scalp serum, not a standalone leading active.
Safety-wise, oral saw palmetto is generally well-tolerated in short-to-medium-term studies; reported adverse effects are usually mild gastrointestinal complaints. Topical use in the published trials is also generally well-tolerated. The systemic side-effect profile of finasteride — including the documented sexual side effects in a subset of men and the post-finasteride syndrome literature that has emerged since — is not shared by topical saw palmetto.
How Unfurl uses saw palmetto in No. 01
Our No. 01 Peptide Hair Growth Serum includes saw palmetto as one of its supporting actives, alongside the five synthetic peptides that lead the formulation (sh-Polypeptide-1, sh-Oligopeptide-10, sh-Polypeptide-11, sh-Oligopeptide-2, sh-Polypeptide-9) and alongside rosemary, arginine, and Scutellaria baicalensis. The reasoning is straightforward: peptides address scalp signaling; saw palmetto addresses the androgen-pathway side of the picture in a structure/function register; rosemary contributes antioxidant and scalp-environment support. The full ingredient list is on the product page — not behind a "proprietary complex" label.
Our No. 02 Botanical Hair Growth Serum sits in the same morning-ritual slot but leads with rosemary, ginger, and a chlorella-and-spirulina marine blend instead of synthetic peptides — a different philosophy for someone who wants a plant-first formulation. Both serums are in the serums collection if you want to compare them side by side.
Neither serum is a drug. Neither regrows hair. Both are consistency products that support the appearance of fuller-looking hair through daily use over eight to twelve weeks, with the four-month mark as the honest evaluation point. The peptides explainer covers the peptide side of the story in more depth.
If you're trying to work out which of the two is a better starting point for your scalp, the hair quiz is the fastest honest sort.
Frequently asked questions
Does saw palmetto actually block DHT?
It inhibits 5-alpha-reductase, the enzyme that produces DHT. "Block" is too strong a word — it reduces activity at the enzyme in the relevant tissues, but at smaller magnitude than finasteride or dutasteride. The NIH ODS fact sheet and the Rossi et al. 2012 comparative study are the cleanest references.
Is saw palmetto as effective as finasteride?
No. The 2012 Rossi comparative reported improvement in 38% of the saw palmetto group versus 68% of the finasteride group at two years. Saw palmetto is in the same mechanistic class at a smaller effect size. It is not an equivalent substitute.
Can I take saw palmetto as a supplement and use a serum with saw palmetto?
Potentially, but this is a physician conversation, not a product-page recommendation. Dosing and interaction considerations — particularly with blood thinners and hormonal medications — warrant clinician input. The NIH ODS fact sheet lists the documented cautions.
Will topical saw palmetto cause side effects?
In the published topical trials — including Wessagowit 2016 — tolerability has generally been good. Serious topical side-effects are not a feature of the literature. Anyone with palm-family plant allergies should avoid it.
Is saw palmetto safe during pregnancy?
The evidence base for saw palmetto use in pregnancy is insufficient, and most reviews — including the NIH ODS fact sheet — recommend avoiding it orally in pregnancy. Topical use is also not a recommendation we make for pregnant or nursing users. Defer to your OB.
How long before I see any effect from a serum containing saw palmetto?
Same timeline as any cosmetic serum: eight to twelve weeks for first visible change, around four months for maximum effect. The ingredient doesn't override the hair cycle. Consistency is the lever.
Our editorial approach. Unfurl content is researched and written by named authors and cross-checked against peer-reviewed literature (PubMed, Cochrane, NIH ODS) before publishing. We cite every claim inline. Articles are editorially reviewed — not medically reviewed — and nothing on this site is medical advice. Talk to a clinician before starting any supplement. These statements have not been evaluated by the FDA.